Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DROMOSTANOLONE Cause Hepatic neoplasm? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatic neoplasm have been filed in association with DROMOSTANOLONE. This represents 11.3% of all adverse event reports for DROMOSTANOLONE.

8
Reports of Hepatic neoplasm with DROMOSTANOLONE
11.3%
of all DROMOSTANOLONE reports
8
Deaths
8
Hospitalizations

How Dangerous Is Hepatic neoplasm From DROMOSTANOLONE?

Of the 8 reports, 8 (100.0%) resulted in death, 8 (100.0%) required hospitalization, and 7 (87.5%) were considered life-threatening.

Is Hepatic neoplasm Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DROMOSTANOLONE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does DROMOSTANOLONE Cause?

Drug abuse (31) Intentional product misuse (16) Secondary hypogonadism (10) Autoimmune thyroiditis (9) Diabetes mellitus (9) Multiple organ dysfunction syndrome (9) Poisoning (8) Haematocrit increased (7) Intra-abdominal haemorrhage (7) Nephropathy (7)

What Other Drugs Cause Hepatic neoplasm?

OCTREOTIDE (300) ADALIMUMAB (98) LANREOTIDE (85) EVEROLIMUS (84) AMLODIPINE (74) ROSUVASTATIN (55) IMATINIB (51) BEVACIZUMAB (49) RIBAVIRIN (49) METFORMIN (47)

Related Pages

DROMOSTANOLONE Full Profile All Hepatic neoplasm Reports All Drugs Causing Hepatic neoplasm DROMOSTANOLONE Demographics